Semaglutide vs tirzepatide: which is better for weight loss?.

Semaglutide vs tirzepatide: which is better for weight loss?

Key takeaways

• Both semaglutide and tirzepatide are effective medications for weight management when appropriately prescribed and used as part of a broader treatment plan.
• Tirzepatide produced greater average weight loss in the head-to-head trial: 20.2% versus 13.7% with semaglutide over 72 weeks in adults with obesity without type 2 diabetes.
• Semaglutide works through the GLP-1 receptor. Tirzepatide works through both GLP-1 and GIP receptors.
• Their most common side effects overlap, especially nausea, diarrhea, vomiting, and constipation. Neither is automatically the safer choice for every person.
• The medication you take matters. So does the way your care is managed: your medical history, response, side effects, dosing, nutrition, movement, and follow-up all shape your treatment experience.

Maybe a friend’s results got you curious, or your doctor brought up medication for weight management. Now you’re comparing semaglutide and tirzepatide and wondering which could help you.

In the strongest direct comparison available, tirzepatide led to greater average weight loss than semaglutide. But picking a medication is only one part of the decision. It needs to fit your health history, how your body responds, what you can tolerate, and what you're actually trying to change over time. That's where medically guided weight-loss care starts to matter as much as either percentage.

Semaglutide vs tirzepatide at a glance

Semaglutide

Tirzepatide

How it works

GLP-1 receptor agonist

Dual GLP-1 and GIP receptor agonist

Weight-loss evidence

Strong evidence from large obesity trials

Strong evidence from large obesity trials

Head-to-head result

13.7% average reduction at 72 weeks

20.2% average reduction at 72 weeks

Common side effects

Nausea, vomiting, diarrhea, constipation, abdominal symptoms

Similar gastrointestinal side effects

What's the difference between semaglutide and tirzepatide?

Both medications belong to the broader family of incretin-based treatments, but semaglutide acts on one hormone pathway and tirzepatide acts on two.

Semaglutide is a GLP-1 receptor agonist. GLP-1 is involved in appetite and fullness, digestion, and blood sugar regulation.

Tirzepatide works on GLP-1 and GIP receptors. GIP, or glucose-dependent insulinotropic polypeptide, adds a second incretin pathway involved in metabolic regulation.

Which GLP treatment works better for weight loss?

In the SURMOUNT-5 trial, more people on tirzepatide reached weight-loss thresholds of 10%, 15%, 20%, and 25%.

Those figures reflect adults with obesity without type 2 diabetes receiving maximum tolerated doses. They can't tell you exactly how your body will respond, and you may respond well to semaglutide, tolerate it comfortably, and make meaningful progress on it.

In that situation, changing medication simply because another treatment has a higher trial average may not improve your care. A clinician may also consider:

• How much weight you want or need to lose
• Your previous response to GLP-1 treatment
• Blood sugar and metabolic health
• Your current medications
• Gastrointestinal symptoms and relevant medical history
• Whether you can tolerate dose increases
• How treatment fits into your nutrition, movement, and longer-term health plan

Semaglutide vs tirzepatide side effects

With both medications, digestive side effects are the most likely thing you'll notice. In the head-to-head trial, gastrointestinal symptoms were the most common issue in both groups, usually mild to moderate and most noticeable while your dose was being increased.

Common side effects can include:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal discomfort

A side effect isn't just something to push through or stop treatment over. It's information: about your dose, how quickly it was increased, your eating patterns, your hydration. Your clinician should be reviewing that with you, so you get clear guidance on whether to continue, pause, or adjust.

Semaglutide vs tirzepatide: which is safer?

Neither medication is universally safer. Your health history, other medications, and response help determine which option fits, while screening and follow-up help manage the risks.

Both medications' labels carry the same core warnings: an FDA boxed warning for thyroid C-cell tumors, based on findings in rodent studies whose relevance to humans hasn't been established, along with warnings for pancreatitis, gallbladder problems, severe gastrointestinal reactions, and kidney injury linked to dehydration. Neither is used in anyone with a personal or family history of medullary thyroid carcinoma or MEN2, which is exactly why your clinician asks about your history before prescribing either one, not after.

Pregnancy planning also affects treatment timing. Wegovy’s prescribing information advises stopping semaglutide at least two months before a planned pregnancy.

If you use oral hormonal contraceptives, tirzepatide's label recommends switching to a non-oral method or adding a barrier method for four weeks after starting and after each dose increase.

The bigger safety gap isn't between the two medications. It's in how people get them. FDA has reported serious dosing errors involving compounded injectable semaglutide, including cases requiring hospitalization. It has also received reports of adverse events involving compounded semaglutide or tirzepatide prescribed beyond approved-label dosing recommendations.

Before you start treatment, your clinician should understand:

• Your medical history and current medications
• Previous GLP-1 experience
• Relevant gastrointestinal, pancreatic, or gallbladder concerns
• Pregnancy or pregnancy planning where relevant
• What you're trying to accomplish with treatment

Once you start, you should have a clear way to ask questions, report side effects, and adjust the plan as you go.

What if semaglutide isn't working as well as you hoped?

Maybe you have been on semaglutide for a while and your progress has slowed. Maybe side effects are becoming harder to manage, or you are doing well and wondering whether tirzepatide could help you reach your goals.

Before changing treatment, look at what is happening:

• How long have you been taking the medication?
• What dose stage have you reached?
• How has your weight changed?
• Has your appetite changed?
• What side effects are you experiencing?
• Are those effects improving, stable, or getting worse?
• Has anything changed in your sleep, stress, movement, nutrition, or medications?

Can you switch from semaglutide to tirzepatide?

A clinician may consider switching when your response, side effects, or another part of your treatment plan makes reassessment worthwhile. The medications are not interchangeable, and there is no simple dose conversion to follow yourself. Your clinician needs to know what you've been taking and how to introduce the next treatment safely. If you are considering switching, start with a GLP weight loss treatment review.

The medication is only one part of medical weight loss

Medication can change appetite and fullness in ways that make weight reduction more achievable for many people. The experience still sits inside a bigger health picture.

A thoughtful weight-management program should consider:

• Nutrition that supports adequate protein and nutrient intake
• Movement and preservation of lean mass
• Sleep and recovery
• Metabolic health
• Other medications or conditions affecting weight
• How weight maintenance will be approached over time

The medication can be an important tool within a plan that supports your health over time.

What to look for in a GLP-1 weight-loss clinic

If you are comparing online providers or clinics, start by looking at how they make the treatment decision. A program should be able to answer:

• Who reviews my health history? A licensed clinician should be involved before treatment is prescribed.
• How is the medication chosen? The answer should involve your health and goals.
• What happens if I have side effects? You should know who to contact and how the plan can change.
• How is progress monitored? Response, tolerance, and relevant health measures should inform follow-up.
• What happens if the first option isn't a good fit? There should be a way to reassess treatment.
• Where does the medication come from? The FDA recommends a clinician's prescription filled through a state-licensed pharmacy, but says compounded drugs should be used when a patient's medical needs cannot be met by an FDA-approved drug.

How Arōe approaches GLP-based weight management

Arōe's weight-management program includes GLP-1 receptor agonist and dual GLP-1/GIP treatment pathways. The starting point is understanding which approach fits your health and goals.

Assess

The conversation starts with your health history, goals, previous weight-management efforts, medications, and factors that may be affecting your weight and metabolic health. If you have already used a GLP-1 medication, your experience becomes part of that conversation too.

Design

A personalized plan considers the treatment options that fit your clinical picture, along with relevant nutrition, movement, and broader health needs. You can ask your clinician why a particular option is being recommended and what progress to expect.

Support

Follow-up gives you space to discuss your response, side effects, questions, and changing goals. Ask how reviews and dose adjustments will be managed as part of your program.

Meet the Arōe team: experienced in metabolic and long-term health

Arōe’s team brings experience across nursing, internal medicine, and preventive care. That background provides context for its approach to individualized weight management.

Founder Lauren Hawkins, BSB, BSN, RN, CCRN, spent close to a decade in nursing, including oncology, critical care, and cardiac intensive care, before founding Arōe around a simple idea: care works better when it's proactive instead of reactive.

Medical Director Dr. Tobi Ogundare has 10 years of internal medicine experience, a specific interest in metabolic, obesity, and holistic medicine. Dr. Ogundare was nominated and serves as an executive member of the Society of Hospital Medicine (SHM), is board certified with the American College of Physicians (ACP), and is an active part of the American Medical Association (AMA).

Primary Nurse Practitioner Michelle Dacto trained at NYU and has spent nine years in healthcare, most of it centered on personalized, preventive care rather than one-size-fits-all treatment.

Between them, you’ll be working with a team that can explain why a treatment does or doesn't fit you, not just prescribe it.

Semaglutide or tirzepatide: where do you start?

The honest answer to "which is better" is that it's the wrong question to answer on your own. It's a question for you and a clinician to work out together, using your actual history, not a headline number from a trial you weren't in.

Maybe you're considering medication for the first time, doing well on semaglutide, or wondering what to do about a plateau. Whatever brought you here, you don't need to arrive at the appointment already knowing the answer.

Begin with an Arōe consultation to discuss your health, goals, and previous response, and find out which treatment pathway fits.

Frequently asked questions

Is tirzepatide better than semaglutide for weight loss?

Tirzepatide produced greater average weight loss in the SURMOUNT-5 trial: 20.2% versus 13.7% with semaglutide after 72 weeks in adults with obesity without type 2 diabetes. Both were effective; the better option for an individual also depends on health history, response, side effects, and other clinical factors.

Does tirzepatide have more side effects than semaglutide?

Both commonly cause nausea, vomiting, diarrhea, and constipation. In the direct comparison, gastrointestinal events were the most common adverse events in both groups and were generally mild to moderate.

How do I choose a GLP-1 weight-loss clinic?

Look for a licensed clinician who reviews your history, explains the treatment choice, monitors your response, and can reassess the plan. You should also know where your medication comes from and whom to contact with questions.